OHK’s premier technology campus is developing exciting, ground-breaking solutions to protect the brain and extend the ‘golden hour’ for emergency care. Led by Prof. Noam Gavriely, MD, DSc, the focus is for practical, effective, and safe solutions to emergency and transport issues. OHK technology includes:
HemaShock, a proven treatment for Hypovolemic Shock & Cardiac Arrest. HemaShock raises systolic & diastolic blood pressure and increases coronary blood flow and cerebral perfusion pressure.
Hema-T, a revolutionary new tourniquet, intended to stop bleeding from an open wound in arm or leg. The unique design addresses three critical deficiencies in combat and first aid tourniquets – adjusting tourniquet pressure incorrectly, wasting the blood volume in the injured limb, and clotting. Hema-T® rolls up the limb and always applies the right pressure to prevent the bleed – independent of the force used during application – and that rolling action shifts the remaining blood from the limb into the body, so it is available to vital organs, and not left in the limb to clot.